RE: research15 Jun 2021 09:33
As at date of publication, 156 patients have been recruited and have completed treatment. The data is now being assessed and outcomes will be reported formally on or about late July 2021. It is the intention of EML to seek a sale of the drug, a license or partnership deal as soon as possible after the data is published.
The above is from the Angelfish RNS. Late July for final results, which should mean initial indications are ahead of the "end of June" expectation.